This targeting ability is attributed to specific surface moieties retained from the parent cells, including tetraspanins (CD9, CD63, CD81), integrins (e.g., αvβ3, α6β4), and phosphatidylserine, which interact with overexpressed receptors on the glioma endothelium and tumor cells. The gene discussed is CD9; the disease is central nervous system cancer.